Management

Iryna Dzieciuch, Chief Executive Officer

Ms. Iryna Dzieciuch has received her M.S. in Artificial Intelligence and M.S. in Bioinformatics and Medical Informatics from San Diego State University, specializing in metagenomics of the oral microbiome. She has been involved with OmniBiome since December 2015 and a co-inventor of diagnostic pre-maternal patent as well as a periodontal patent filed at OmniBiome Inc. Ms. Iryna Dzieciuch has been developing consumer products that regulate systemic effects of the natural human microbiome on dental and maternal health. She has recognized the effect of virulence mechanisms and other pathogen traits involved in onset of periodontal disease.

San Diego State University-California State University
Master’s degree, Bioinformatics and Medical Informatics, 3.00

2011 – 2014

Analysis Metagenomics Data from Oral Microbiome Project
Activities and Societies: Periodontal Microbiome Project, Dr. Scott Kelley’s Lab 1 honor or award
National Technical University of Ukraine ‘Kyiv Polytechnic Institute’
Master’s Degree, Computer Science, Artificial Intelligence, 3.53

2003 – 2005

Activities and Societies: Petrosyuk Iryna, Neuro-fuzzy Model for Image Processing in Electro-optical Applications Lviv-Slavsko, Modern Problems of Radio Engineering, Telecommunications, and Computer Science, 2006. TCSET 2006. International Conference, Nat. Tech. Univ. of Ukraine, Kyiv, pages 218-221, February 28-March 4 2006

Vinnytsia National Technical University
Bachelor’s Degree, Computer Science

1999 – 2003

Gerry B. Berg, Chief Financial Officer & Director

Mr. Berg has served the Company as Vice President, Chief Financial Officer and Director since its incorporation in 2015. Mr. Berg has over thirty-five years of senior management experience working with private and public companies. His career emphasis has been on Finance and Operations. Mr. Berg has over five years of experience having served as the Vice President of Operations and Chief Financial Officer for two nutraceutical companies. As part of his responsibilities, Mr. Berg was responsible for raw material purchasing and compliance, manufacturing in accordance with cGMP procedures, and FDA and FCC guidelines for marketing.

Mr. Berg holds a Bachelors of Science in Accounting from Walsh College where he graduated Cum Laude. Mr. Berg became a Certified Public Accountant (CPA) in the State of Michigan in 1979 and in the State of California in 1984. Mr. Berg does not currently practice as a CPA.

Dr. Vijay Mahant, Chief Science Officer

Dr. Mahant has been involved in Research and Development in the medical industry for close to 30 years. Working in the FDA regulated medical industry, he has headed R&D activities for several bio-medical companies as well as being the founder, CEO & Chairman of MediLite, Inc.

Dr. Mahant has specialized in the areas of assay development, has numerous patents to his credit and has published extensively. Dr. Mahant received his B.S. in Biochemistry from the University of Salford, UK; a M.S. in Medicinal Chemistry and a Ph.D. in Medical Biochemistry from Lougborough University of Technology, UK.

Timothy G. Dixon, President & Chairman

Mr. Dixon has served the Company as President and Chairman of the Board since its incorporation in 2015. Mr. Dixon currently serves as Chief Executive Officer and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011.

Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies.

SCIENTIFIC ADVISORY BOARD

Dr. Barry Glassman, DMD, DAAPM, DAACP, FICCMO, Diplomate ABDSM, FADI, is a Diplomate of the American Academy of Craniofacial Pain and the American Academy of Pain Management, as well as a Fellow of the International College of Craniomandibular Orthopedics and the Academy of Dentistry International, he is also on staff at the Lehigh Valley Hospital where he serves as a resident instructor of Craniofacial Pain and Dysfunction and Dental Sleep Medicine.

Dr. Glassman is a Diplomat of the Academy of Dental Sleep Medicine. He is on the staff at the Sacred Heart Hospital Sleep Disorder Center, as well as serving as the Chief Dental Consultant to three other sleep centers in the Lehigh Valley.

A popular and dynamic speaker, Dr. Glassman lectures internationally, as well as throughout the United States. In addition to his extensive schedule which includes guest lecture appearances and in-depth courses on joint dysfunction, chronic pain, headache, sleep disorders, and migraine headache, Dr. Glassman is a frequent speaker at major chronic pain and joint dysfunction professional conferences.

University of Pittsburgh: Bachelor of Science 1969, Pittsburgh, Pennsylvania

University of Pittsburgh School of Dental Medicine; D.M.D. 1973, Pittsburgh Pennsylvania

Post Graduate Hours in Craniomandibular Dysfunction and Sleep Disorders: Over 2500